Acitretin and Methotrexate Outperform Cyclosporine in Pediatric Psoriasis Maintenance: Study Shows
- byDoctor News Daily Team
- 29 October, 2025
- 0 Comments
- 0 Mins
 
                            France: Researchers have found in a multinational study involving 506 pediatricpsoriasispatients that acitretin andmethotrexatedemonstrated comparable 2-year drug survival rates, both significantly superior tocyclosporine. The analysis, which covered 683 treatment courses across five countries, highlighted better long-term maintenance with acitretin and methotrexate compared to cyclosporine.
    Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
    The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
    Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
    If you come across any inconsistencies, please reach out to us at 
    admin@doctornewsdaily.com.
    We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
    By using this website, you agree to our 
    Terms of Use, 
    Privacy Policy, and 
    Advertisement Policy.
    For further details, please review our 
    Full Disclaimer.
Recent News
Scientists discover a hidden antibiotic 100 times...
- 31 October, 2025
Gut microbes may convert fiber into extra calories...
- 31 October, 2025
Who's eligible for faculty appointment? NMC clarif...
- 31 October, 2025
AMU JN Medical College launches code blue emergenc...
- 31 October, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
 
                     
                    
0 Comments
Post a comment
No comments yet. Be the first to comment!